Commercial watercress as an emerging source of fascioliasis in Northern France in 2002: Results from an outbreak investigation

Epidemiology and Infection

Volumn 134, Issue 5, 2006, Pages 942-945

  Mailles, A ^a   Capek, A ^a   Ajana, F ^b   Schepens, C ^c   Ilef, D ^c   Vaillant, V ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b Service des Maladies Infectieuses et Tropicales   (France)

^c ETS Nord Pas de Calais   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ASTHENIA; CASE CONTROL STUDY; CASE FINDING; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; FASCIOLIASIS; FEMALE; FEVER; FOOD INTAKE; FRANCE; HUMAN; INFECTION CONTROL; INFESTATION; INTERVIEW; LYMNAEA; MALE; MYALGIA; PRURITUS; RAW FOOD; SANITATION; SEROLOGY; STATISTICAL ANALYSIS; SYMPTOM; WATERCRESS;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DISEASE OUTBREAKS; FASCIOLIASIS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; VEGETABLES;

EID: 33748370335     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880600611X     Document Type: Article

References (12)

1. Richter J, et al. Fasciolasis. Current Treatment Options in Infectious Diseases 2002; 4: 313-317.
2. Ripert C. Liver distomatosis [in French]. In: Ripert C, ed. Epidémiologie des maladies parasitaires - 2 Helminthoses. Cachan: Editions médicales internationales, 1998: 115-147.
3. Price TA, Tuazon CU, Simon GL. Fascioliasis: Case reports and review. Clinical Infectious Diseases 1993; 17: 426-430.
4. Noyer CM, et al. Hypereosinophilia and liver mass in an immigrant. American Journal of Tropical Medicine and Hygiene 2002; 66: 774-776.
5. Acosta-Ferreira W, Vercelli-Retta J, Falconi LM. Fasciola hepatica human infection. Histopathological study of sixteen cases. Virchows Archiv A, Pathological Anatomy and Histopathology 1979; 383: 319-327.
6. Graham CS, Brodie SB, Weller PF. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole. Clinical Infectious Diseases 2001; 33: 1-5.
7. Millan JC, et al. The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection. American Journal of Tropical Medicine and Hygiene 2000; 63: 264-269.
8. Vaillant V, et al. (eds). Morbidity and mortality of foodborne infections in France [in French]. Saint Maurice, France: Institut de Veille Sanitaire, June 2003: 161-164 (http://www.invs.sante.fr/ publications/2004/inf_origine_alimentaire/inf_origine_alimentaire.pdf).
9. e série) 1978; 23: 292-296.
10. Demirci M, et al. Fascioliasis in eosinophilic patients in the Isparta region of Turkey. Infection 2003; 31: 15-18.
11. Hugues AJ, et al. Human fasciolosis acquired in an Australian urban setting. Medical Journal of Australia 2003; 178: 244-245.
12. Dreyfuss G, Vignoles P, Rondelaud D. Fasciola hepatica: Epidemiological surveillance of natural watercress beds in central France. Parasitology Research 2005; 95: 278-282.